CD8A and cancer: FMT can restore gut microbial diversity and increase probiotic abundance in cancer patients, maintain microbiome homeostasis, enhance production of beneficial metabolites such as SCFAs, promote DCs maturation and antigen presentation, and bolster effector and memory differentiation of CD8+ T cells within the TME, thereby markedly improving antitumor immunity [24, 227–230].